Koen Vermeulen

Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells

Manon Lernoux, Michaël Schnekenburger, Hélène Losson et al. · Clinical Epigenetics · 2020 · 53 citations · Full text

Evaluation of [¹¹C]NMS-E973 as a PET tracer for <i>in vivo</i> visualisation of HSP90

Koen Vermeulen, Evelyne Naus, Muneer Ahamed et al. · Theranostics · 2019 · 25 citations · Full text

Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma

Koen Vermeulen, Muneer Ahamed, Kaat Luyten et al. · Nuclear Medicine and Biology · 2019 · 15 citations

Engineering, Oncologic Imaging, B16.f10 Melanoma +18

Characterization of Non-Specific Uptake and Retention Mechanisms of [177Lu]Lu-PSMA-617 in the Salivary Glands

Nathalie Heynickx, Charlotte Segers, Amelie Coolkens et al. · Pharmaceuticals · 2023 · 12 citations · Full text

The Emission of Internal Conversion Electrons Rather Than Auger Electrons Increased the Nucleus-Absorbed Dose for¹⁶¹Tb Compared with¹⁷⁷Lu with a Higher Dose Response for [¹⁶¹Tb]Tb-DOTA-LM3 Than for [¹⁶¹Tb]Tb-DOTATATE

Kaat Spoormans, Lara Struelens, Koen Vermeulen et al. · Journal of Nuclear Medicine · 2024 · 12 citations · Full text